Skip to main content
Clinical Trials/ACTRN12607000068460
ACTRN12607000068460
Not yet recruiting
未知

A Multicentre Prospective Study to Investigate the Prevalence of Sexual Dysfunction and Quality of Life in Women with Breast Cancer receiving Aromatase Inhibitors

Professor Michael Friedlander0 sites200 target enrollmentJanuary 22, 2007

Overview

Phase
未知
Intervention
Not specified
Conditions
Sexual Dysfunction
Sponsor
Professor Michael Friedlander
Enrollment
200
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 22, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Professor Michael Friedlander

Eligibility Criteria

Inclusion Criteria

  • Primary breast cancer. Post\-menopausal (no menstrual periods for at least 6 months). 6\-8 weeks post chemotherapy Not receiving adjuvant anti\-oestrogen therapy at time of study entry Fluent in English Willingness to complete questionnaire.

Exclusion Criteria

  • Diagnosis of metastatic breast cancer.

Outcomes

Primary Outcomes

Not specified

Similar Trials